Enliven Therapeutics to Present at Two Upcoming Investor Conferences

Format: Fireside Chat Date: Wednesday, June 5 Time: 8:30 a.m. ET BOULDER, Colo., May 29, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next- generation small molecule kinase inhibitors, today announced that management will present at the following investor conferences in June: Jefferies Global Healthcare Conference Contact Goldman Sachs Annual Global Healthcare Conference Investors ir@enli ...